Mark Sabag

TEVA

Mark Sabag serves as See "Remarks" at Teva Pharmaceutical Industries Limited (TEVA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$12.33M

Net Position

Net Seller

$12.33M

Companies Traded

TEVA

Active Period

May 2025 – Dec 2025

2 total trades

Most Recent

Sell TEVA

Dec 9, 2025 · $6.23M

Mark Sabag's Insider Trading at Teva Pharmaceutical Industries Limited (TEVA)

Buys

0 · $0.00

Sells

2 · $12.33M

Total Shares Bought

Total Shares Sold

554,807

TEVA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 9, 2025↗	Sell	216,892	$28.73	$6.23M	0
May 8, 2025↗	Sell	337,915	$18.04	$6.10M	0

Related Insiders

MIGNONE ROBERTO

Director

TEVASell · Dec 16, 2025

Amir Weiss

Chief Accounting Officer

TEVASell · Dec 16, 2025

Richard Daniell

Exec. VP, European Commercial

TEVASell · Dec 9, 2025

Christine Fox

EVP, Head of U.S. Commercial

TEVASell · Nov 20, 2025

David R. McAvoy

EVP, Chief Legal Officer

TEVABuy · Sep 5, 2025

Placid Jover

See "Remarks"

TEVASell · Aug 1, 2025

Eric A Hughes

See "Remarks"

TEVASell · Aug 1, 2025

Eliyahu Sharon Kalif

EVP, Chief Financial Officer

TEVASell · Jun 12, 2025

Explore More Insider Trading Data

TEVA Insider Trading Activity

View all insider trades at Teva Pharmaceutical Industries Limited

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity